Cellular Efficacy of Fattigated Nanoparticles and Real-Time ROS Occurrence Using Microfluidic Hepatocarcinoma Chip System: Effect of Anticancer Drug Solubility and Shear Stress
Pharmaceuticals · 20.09.2023 · 16 (9) · 1330
DOI: 10.3390/ph16091330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 20.09.2023. Verfasst von Hoyoung Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Evaluation Institute of Industrial Technology, Ministry of Trade, Industry, and Energy.
Abstract (Originalsprache)
The objective of this study was to evaluate the effectiveness of organ-on-chip system investigating simultaneous cellular efficacy and real-time reactive oxygen species (ROS) occurrence of anticancer drug-loaded nanoparticles (NPs) using hepatocarcinoma cells (HepG2) chip system under static and hepatomimicking shear stress conditions (5 dyne/cm2). Then, the role of hepatomimetic shear stress exposed to HepG2 and drug solubility were compared. The highly soluble doxorubicin (DOX) and poorly soluble paclitaxel (PTX) were chosen. Fattigated NPs (AONs) were formed via self-assembly of amphiphilic albumin (HSA)-oleic acid conjugate (AOC). Then, drug-loaded AONs (DOX-AON or PTX-AON) were exposed to a serum-free HepG2 medium at 37 °C and 5% carbon dioxide for 24 h using a real-time ROS sensor chip-based microfluidic system. The cellular efficacy and simultaneous ROS occurrence of free drugs and drug-loaded AONs were compared. The cellular efficacy of drug-loaded AONs varied in a dose-dependent manner and were consistently correlated with real-time of ROS occurrence. Drug-loaded AONs increased the intracellular fluorescence intensity and decreased the cellular efficacy compared to free drugs under dynamic conditions. The half-maximal inhibitory concentration (IC50) values of free DOX (13.4 μg/mL) and PTX (54.44 μg/mL) under static conditions decreased to 11.79 and 38.43 μg/mL, respectively, under dynamic conditions. Furthermore, DOX- and PTX-AONs showed highly decreased IC50 values of 5.613 and 21.86 μg/mL, respectively, as compared to free drugs under dynamic conditions. It was evident that cellular efficacy and real-time ROS occurrence were well-correlated and highly dependent on the drug-loaded nanostructure, drug solubility and physiological shear stress.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
- College of Pharmacy, Jeju National University, Jeju 63243, Republic of Korea.
- Advanced Micro-Mechatronics Lab, Mechatronics Engineering, Jeju National University, Jeju 63243, Republic of Korea.
- BioSpero, Jeju 63309, Republic of Korea.
- College of Pharmacy, Sahmyook University, Seoul 01795, Republic of Korea.
ORCID-Profile: Hai V Ngo, Hy D Nguyen, Chulhun Park, Jun-Bom Park, Beom-Jin Lee
Förderung
- Korea Evaluation Institute of Industrial Technology
- Ministry of Trade, Industry, and Energy
Zitieren
APA
Kim, H., Kim, E. J., Ngo, H. V., Nguyen, H. D., Park, C., Choi, K. H., Park, J. B., & Lee, B. J. (2023). Cellular Efficacy of Fattigated Nanoparticles and Real-Time ROS Occurrence Using Microfluidic Hepatocarcinoma Chip System: Effect of Anticancer Drug Solubility and Shear Stress. Pharmaceuticals, 16(9), 1330. https://doi.org/10.3390/ph16091330
Vancouver
Kim H, Kim EJ, Ngo HV, Nguyen HD, Park C, Choi KH, et al. Cellular Efficacy of Fattigated Nanoparticles and Real-Time ROS Occurrence Using Microfluidic Hepatocarcinoma Chip System: Effect of Anticancer Drug Solubility and Shear Stress. Pharmaceuticals. 2023;16(9):1330. doi:10.3390/ph16091330
BibTeX
@article{Kim2023,
author = {Kim, Hoyoung and Kim, Eun-Ji and Ngo, Hai V and Nguyen, Hy D and Park, Chulhun and Choi, Kyung Hyun and Park, Jun-Bom and Lee, Beom-Jin},
title = {Cellular Efficacy of Fattigated Nanoparticles and Real-Time ROS Occurrence Using Microfluidic Hepatocarcinoma Chip System: Effect of Anticancer Drug Solubility and Shear Stress},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {9},
pages = {1330},
doi = {10.3390/ph16091330}
}
EUVIMED